• Skip to Content
  • Skip to Sidebar
IU

Indiana University Bloomington Indiana University Bloomington IU Bloomington

Menu

ScIUConversations in Science at Indiana University

  • Home
  • Home
  • About ScIU
  • Write with Us!
  • Contact ScIU
  • The Writers and Editors of ScIU
  • ScIU in the Classroom
  • Annual Science Communication Symposium
  • Search

Harnessing the therapeutic benefits of marijuana: Research findings from Dr. Andrea Hohmann’s laboratory at Indiana University presented at international neuroscience conference

Posted on November 23, 2016 by Rachel Skipper

Text box that reads: "ScIU Current Events"Last week, over 32,000 neuroscientists met in San Diego for the annual Society for Neuroscience (SfN) conference. Joining them were members of IU’s Program in Neuroscience, including Dr. Andrea Hohmann, who is also a professor in the Department of Psychological and Brain Sciences in the College of Arts in Sciences and a Linda and Jack Gill Chair of Neuroscience in the Gill Center for Biomolecular Science.

Scientific conferences like SfN bring together scientists from all over the world to discuss their findings. Researchers attend SfN to discuss a wide variety of topics related to brain function and mental health. At the conference, Dr. Hohmann met not only with her colleagues, but also members of the press, who were interested in her lab’s research on the neurochemistry of pain. She described how the endocannabinoid system, a complex network of cells and receptors in the brain, is involved in pain perception and may be a useful target for pain relief drugs. The endocannabinoid system is currently a hot topic in neuroscience, partly because receptors in this system are targeted by THC, the psychoactive ingredient in marijuana and other synthetic marijuana-like compounds. When THC and other synthetic cannabinoids reach the brain, they act on cannabinoid receptors to elicit both psychoactive and pain-relieving effects. Marijuana is currently being considered for legalization in the US. 

Dr. Hohmann has received funding from the National Institute on Drug Abuse to test compounds that could mimic the pain-relieving effects of these compounds without producing their other psychoactive effects. This is an exciting new avenue in drug research. As Dr. Hohmann puts it: “The most exciting aspect of this research is the potential to produce the same therapeutic benefits as opioid-based pain relievers without side effects like addiction risk or increased tolerance over time.”

Richard Slivicki, a graduate student in Dr. Hohmann’s lab, conducted an experiment to test the effects of THC-like drugs in mice with chronic pain. He showed that, when mice with chronic pain were given these compounds, their behavior changed dramatically. Rather than showing heightened responses that are typical of mice with chronic pain, they responded normally when pressure or cold stimulation was applied to their paws. Importantly, Slivicki also found that these effects were long-lasting. While other drugs that target the endocannabinoid system become less effective over time, this drug remained effective even after multiple exposures. “A common issue with current chronic pain therapies such as opioids is that tolerance follows chronic dosing with these compounds. With this approach we don’t find tolerance or other issues that plague current therapies,” Slivicki stated. Other benefits of these drugs are that they are more specific than THC, as they amplify the activity of the brain’s own cannabis-like compounds at only some cannabinoid receptors and not others. Further, the drugs do not possess addictive properties and mice do not show withdrawal symptoms after chronic treatment.

Not surprisingly, this finding was a hit at SfN.  As marijuana becomes legal for recreational and medicinal use in an increasing number of American states, neuroscientists are working hard to understand how THC and other similar compounds produce their effects. Hohmann, Slivicki, and others will continue to search for ways to harness the pain-reducing benefits of these compounds to provide healthier and more effective alternatives to current pain management drugs.

Want to learn more? Check out the SfN press release and this article by IU reporter Kevin Fryling, who interviewed Dr. Hohmann and Rich Slivicki before the conference.

Edited by Briana K. Whitaker and Lana Ruck

Print Friendly, PDF & Email

Related

Filed under: Current Events, Spotlight on PeopleTagged cannabis, neuroscience, pharmaceuticals, Society for Neuroscience

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Search ScIU

Categories

Tag cloud

#Education #scicomm animal behavior anthropology archaeology astronomy astrophysics Biology Black History Month Black Lives Matter brain Chemistry climate change Collaboration conservation coronavirus COVID–19 diversity Diversity in Science diversity in STEM Ecology endocrinology Environmental Resilience Institute evolution history and philosophy of science infectious disease Interdisciplinary Interview Mental Health methods microbiology neuroscience outreach Plants primates psychology Research science communication science education Science Outreach science policy Statistics STEM technology women in STEM

Subscribe

Receive a weekly email with our new content! We will not share or use your information for any other purposes, and you may opt out at any time.

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Current Contributors

  • Log in
  • Workspace
  • Sign up to write

Indiana University

Copyright © 2018 The Trustees of Indiana University | Privacy Notice | Accessibility Help

  • Home
  • About ScIU
  • Write with Us!
  • Contact ScIU
  • The Writers and Editors of ScIU
  • ScIU in the Classroom
  • Annual Science Communication Symposium
College of Arts + Sciences

Are you a graduate student at IUB? Would you like to write for ScIU? Email sciucomm@iu.edu


Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.